Using lipopolysaccharide (LPS) as a treatment for hepatocellular carcinoma (HCC), He et al. (2017) demonstrated that the increased internal cholesterol concentrations were due to upregulation of LDLR and HMGCR. Here, HMGCR is linked to hepatocellular carcinoma.